Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1945]
News [3579]
Articles [92]
Editorials [5]
Conferences [157]
elearning [19]
Haemato-oncological Cancers
Dr Nikita Mehra - Cancer Institute (WIA), Chennai, India
Haemato-oncological Cancers ( Dr Nikita Mehra - Cancer Institute (WIA), Chennai, India )
7 Nov 2023
Selpercatinib benefit, with or without pembro, in first-line advanced RET...
Dr Herbert Ho Fung Loong - The Chinese University of Hong Kong, Hong Kong
Selpercatinib benefit, with or without pembro, in first-line advanced RET fusion-positive NSCLC ( Dr Herbert Ho Fung Loong - The Chinese University of Hong Kong, Hong Kong )
23 Oct 2023
ESMO 2023: Latest updates in mRCC
Dr Javier Puente, Dr Laurence Albiges, Prof Viktor Grünwald and Prof Stéphane...
ESMO 2023: Latest updates in mRCC ( Dr Javier Puente, Dr Laurence Albiges, Prof Viktor Grünwald and Prof Stéphane Oudard )
23 Oct 2023
Datopotamab deruxtecan extends PFS vs chemo for HR+/HER2- breast cancer
Dr Aditya Bardia - Mass General Cancer Center, Boston, USA
Datopotamab deruxtecan extends PFS vs chemo for HR+/HER2- breast cancer ( Dr Aditya Bardia - Mass General Cancer Center, Boston, USA )
23 Oct 2023
Enfortumab vedotin plus pembrolizumab improves overall survival for advanced...
Prof Thomas Powles - Barts Cancer Centre, London, UK
Enfortumab vedotin plus pembrolizumab improves overall survival for advanced bladder cancer ( Prof Thomas Powles - Barts Cancer Centre, London, UK )
22 Oct 2023
Nivolumab plus gemcitabine-cisplatin shows benefit for locally advanced mUC
Dr Michiel Van der Heijden - Netherlands Cancer Institute, Amsterdam...
Nivolumab plus gemcitabine-cisplatin shows benefit for locally advanced mUC ( Dr Michiel Van der Heijden - Netherlands Cancer Institute, Amsterdam, Netherlands )
22 Oct 2023
Durvalumab addition to chemo shows endometrial cancer benefit
Prof Shannon Westin - University of Texas MD Anderson Cancer Center, Houston...
Durvalumab addition to chemo shows endometrial cancer benefit ( Prof Shannon Westin - University of Texas MD Anderson Cancer Center, Houston, USA )
21 Oct 2023
Adagrasib pembrolizumab combo shows promise for KRASG12C-positive NSCLC
Dr Pasi Janne - Dana-Farber Cancer Institute, Boston, USA
Adagrasib pembrolizumab combo shows promise for KRASG12C-positive NSCLC ( Dr Pasi Janne - Dana-Farber Cancer Institute, Boston, USA )
21 Oct 2023
CheckMate-77T: Perioperative nivolumab benefit for NSCLC
Dr Tina Cascone - MD Anderson Cancer Center, Houston, USA
CheckMate-77T: Perioperative nivolumab benefit for NSCLC ( Dr Tina Cascone - MD Anderson Cancer Center, Houston, USA )
21 Oct 2023
Cost-benefit analysis of new cancer medicines: The difficult choices of...
Dr Nwamaka Lasebikan, Prof P.G. Roy, Dr Didier Verhoeven
Cost-benefit analysis of new cancer medicines: The difficult choices of governments ( Dr Nwamaka Lasebikan, Prof P.G. Roy, Dr Didier Verhoeven )
8 Oct 2023
IMS 2023: Multiple myeloma roundup
Prof Philippe Moreau - University Hospital of Nantes, Nantes, France
IMS 2023: Multiple myeloma roundup ( Prof Philippe Moreau - University Hospital of Nantes, Nantes, France )
3 Oct 2023
OncoAlert Round Up for September 22-28, 2023
Dr Gil Morgan - Executive Director, OncoAlert
OncoAlert Round Up for September 22-28, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )
3 Oct 2023

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation